BATL strives to enable workforce training alongside global medical regulatory convergence in an effort to assist in accelerated drug approvals and ultimate drug access for patients.
Our diverse, innovative, and globally-recognized experiential learning and credentialing programs offer a neutral platform to train the industry’s workforce while also converging the intricacies of global regulatory considerations for pharmaceutical and biopharmaceutical products. In doing so, we increase the potential of accelerated drug approvals with quality, safety and efficacy at the forefront, thus impacting patients for improved access to medicines worldwide.
Ask about our one-day crash course in Protein Structure Analytics in Developing Biopharmaceuticals.
Sept. 10, 2019 – BATL and NIBRT will host a symposium highlighting a collaboration on biomanufacturing & bioanalytics.
If you have any questions about what we do, our courses, or our global impact, feel free to reach out.
A COMMITMENT TO
Research in biotherapeutics is providing promising and innovative drugs that provide hope to millions of patients around the world. Yet these same drugs may pose risks, especially if the challenges inherent in their production, distribution, and marketing are not properly understood and regulated.
The Center of Excellence for Biotherapeutics at Northeastern University’s Biopharmaceutical Analysis Training Laboratory (BATL) will help build expertise and know-how by bringing together scientists and regulators from around the globe for experiential education in these new technologies.